Argenx Se (ARGX) Net Margin (2016 - 2026)

Argenx Se (ARGX) posted Net Margin of 28.2% for Q1 2026, down 31.98% on a QoQ basis from 41.45% in Q4 2025, and up 680.0% year-over-year from 3.62% in Q1 2025.

Argenx Se (ARGX) Net Margin (2016 - 2026) Analysis & Trends

Argenx Se's Net Margin history runs 11 years deep, the most recent figure standing at 28.2% for Q1 2026.

  • Quarterly Net Margin rose 680.0% year-over-year to 28.2% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 31.95% (down 932.0% YoY) and the FY2025 annual result came in at 31.12%, down 699.0% from the prior year.
  • Net Margin was 28.2% for Q1 2026 at Argenx Se, down from 41.45% in the prior quarter.
  • Across five years, Net Margin topped out at 886.14% in Q2 2022 and bottomed at 1073.51% in Q1 2022.
  • A 5-year average of 13.32% and a median of 6.09% in 2024 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2022 — Net Margin sank 104794 bps — and 2023, when it surged 106026 bps.
  • Argenx Se's Net Margin stood at 22.27% in 2022, then decreased by 19 bps to 26.49% in 2023, then soared by 497 bps to 105.05% in 2024, then plunged by 61 bps to 41.45% in 2025, then sank by 32 bps to 28.2% in 2026.
  • Business Quant data shows ARGX's Net Margin at 28.2% in Q1 2026, 41.45% in Q4 2025, and 30.55% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 15.02%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 20.17%
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 28.20%
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 17.65%

Historic Data

Download Data
DateValue
Mar 31, 2026 28.20%
Dec 31, 2025 41.45%
Sep 30, 2025 30.55%
Jun 30, 2025 25.87%
Mar 31, 2025 21.39%
Dec 31, 2024 105.05%
Sep 30, 2024 15.95%
Jun 30, 2024 6.09%
Mar 31, 2024 -15.47%
Dec 31, 2023 -26.49%
Sep 30, 2023 -22.07%
Jun 30, 2023 -35.04%
Mar 31, 2023 -13.24%
Dec 31, 2022 -22.27%
Sep 30, 2022 -178.97%
Jun 30, 2022 886.14%
Mar 31, 2022 -1,073.51%
Dec 31, 2021 -913.91%
Sep 30, 2021 -0.03%
Jun 30, 2021 -164.36%